Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2804 Claudin-18 Is a Sensitive and a Specific Marker for Gastric Neuroendocrine Tumors
Introduction: Antibody-based cancer therapies are emerging as promising therapeutics in oncology, including one in clinical trials that targets claudin-18, a protein expressed in normal gastric epithelium and some gastric adenocarcinoma. We currently have no markers for gastric well-differentiated neuroendocrine tumors (NETs).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Wong M, Huynh C, Kim S, Dhall D, Guindi M,
Keywords: claudin-18, anti-claudin 18, neuroendocrine tumor, neuroendocrine hyperplasia, autoimmune metaplastic atrophic gastritis,
Introduction: Gastric neuroendocrine neoplasms (g-NENs) are a group of rare tumors with a strong heterogeneity, subdivided as well-differentiated neuroendocrine tumors (NETs, type 1-3 g-NETs) and poorly-differentiated neuroendocrine carcinoma(NECs). WHO classification(2019) for digestive system tumours has carried out a new classification and grading criteria for NENs of the gastrointestinal tract recently, there is very few relevant clinical data based on this new classification, especially for gastric NETs(g-NETs).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Li Y, Tan H, Jie C, Jie L, Pan Z,
Keywords: clinicopathological features, prognostic analysis, well-differentiated gastric neuroendocrine tumors, grade, type,
Introduction: There is previous data demonstrating that elevated gastrin levels could exert some effect potentiating the glucose-induced insulin secretion.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Mavroeidi V
Authors: Moschouris P, Mavroeidi V, Nikolopoulos G, Tsoli M, Karapanagioti A,
Keywords: Gastric Neuroendocrine Tumors Type 1, ECL-Cells Hyperplasia, gastrin, glucose,
#2134 Clinicopathological Features of 63 Cases with Type 3 Gastric Neuroendocrine Tumors
Introduction: Well-differentiated gastric neuroendocrine tumors (g-NET) are divided into three distinct types (type 1, type 2 and type 3),there are few studies on the clinicopathologic features of type 3 g-NET.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Tan H
Authors: Qiu X, Yuan B, Zhang Y, Dou D, Liu J,
Keywords: type 3 g-NET, clinicopathological features, survival,
#2077 Linked Colour Imaging Increases the Diagnostic Yield of Type 1 Gastric Carcinoids
Introduction: Type 1 Gastric carcinoid tumours (GCTs) are the most common neuroendocrine tumours of the stomach. Endoscopic diagnosis of Type 1 GCTs remains a challenge. White light endoscopy (WLE) and Narrow Band Imaging (NBI) have failed to demonstrate reliable endoscopic signs of carcinoid.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Gulati S
Authors: Gulati S, Sriraja R, Ramage J, Emmanuel A, Haji A,
Keywords: gastric carcinoid, gastric neuroendocrine tumors, endoscopy, therapy, surveillance, polypectomy, endoscopic resection,